Background: The prevalence of anxiety and depression symptoms among caretakers of children with atopic dermatitis (AD) and associated factors is unclear. The study was designed to explore anxiety and depression symptoms among caretakers of AD, and screen factors associated with anxiety and depression symptoms.Methods: A total of 901 children with AD and their caretakers were continuously enrolled and interviewed at dermatology department of Capital Institute of Pediatrics, Beijing, China. Children’s medication was administered by their caretakers. Caretakers’ anxiety and depression symptoms were evaluated by Hamilton Depression Rating Scale-17 and Hamilton Depression Rating Scale, while medication compliance was evaluated and divided into poor (< 6 points), moderate (6–7 points), and good (> 7 points) by Morisky Medication Adherence Scale. Multilevel ordered logistic regression was used to screen factors associated with caretakers’ anxiety and depression.Results: Among caretakers, 41.5% had anxiety symptoms, 39.6% had depression symptoms, 51.4% have any of the two and 29.7% had both of the two. Factors associated with caretakers’ anxiety symptoms included longer duration of the illness (OR, 0.99, 95% CI 0.98–0.99) and taking care of children with severe AD (OR, 2.55, 95% CI 1.43–4.55). Factors associated with caretakers’ depression symptoms included higher educational level (OR, 0.56, 95% CI 0.39–0.80), taking care of children with moderate (OR, 2.01, 95% CI 1.15–3.50) and severe AD (OR, 3.99, 95% CI 2.10–7.59) and poor medication compliance (OR, 3.45, 95% CI 1.13–10.56).Conclusions: Prevalence of anxiety and depression symptoms among caretakers of AD were high. Attention should be paid to caretakers of AD at higher risk for those psychological problems.
Port wine stains (PWS) are congenital capillary malformations that affect the quality of life for children. Hemoporfin-mediated photodynamic therapy (HMME-PDT) is a promising therapeutic modality for patients with PWS. However, the variability in the clinical efficacy of HMME-PDT has necessitated further investigations into the factors influencing the therapeutic efficacy of this modality. To explore the correlation between dermoscopic vascular features and the efficacy of HMME-PDT in previously untreated children with PWS. Clinical data were collected from children with PWS who were treated with HMME-PDT. Correlations between clinical efficacy and gender, age, lesion location, lesion color and dermoscopic vascular features were analyzed retrospectively in previously untreated children with PWS. A total of 100 previously untreated children with PWS were enrolled, including 52 males and 48 females aged between 1 and 14 years. The efficacy of HMME-PDT differed significantly in relation to lesion location and color of the PWS (P < 0.05). Sausage-like vessels (66.67 %), dotted and globular vessels (87.50 %) and linear vessels (50.00 %) were associated with excellent treatment outcomes. Reticular vessels (65.00 %) showed improved outcomes. HMME-PDT was not effective in some cases with homogeneous reddish background (35.71 %) features. No serious adverse events and recurrences were observed following HMME-PDT. The dermoscopic vascular features showed a significant correlation with the effectiveness of HMME-PDT in previously untreated children with PWS. Thus, the vascular features of PWS classified by dermoscopy can provide helpful clinical information to evaluate the efficacy of HMME-PDT and develop individualized treatment program for children with PWS.
A lot of congenital melanocytic nevi (CMN) carry the somatic mutation in the oncogene BRAF V600E. But the detailed histopathologic characteristics and the proliferative activity of CMN with BRAF V600E gene mutation have not been systematically documented. To identify the proliferative activity and histopathological features correlating them with BRAF V600E gene mutation status in CMN. CMN were retrospectively identified from the laboratory reporting system. Mutations were determined by Sanger sequencing. The CMN were divided into a mutant group and control group according to whether there was BRAF gene mutation and were strictly matched according to gender, age, nevus size, and location. Histopathological analysis, analysis of Ki67 expression by immunohistochemistry and laser confocal fluorescence microscopy were performed. The differences in Ki67 index, the depth of nevus cell involvement and the number of nevus cell nests between the mutant group and the control group was statistically significant, with p-values of 0.041, 0.002 and 0.007, respectively. Compared with BRAF V600E negative nevi, BRAF V600E positive nevi often exhibited predominantly nested intraepidermal melanocytes, and larger junctional nests, but the difference in this data sets were not statistically significant. The number of nests (p = 0.001) was positively correlated with the proportion of Ki67 positive cells. A small sample of patients were included and there was no follow-up. BRAF V600E gene mutations were associated with high proliferative activity and distinct histopathological features in congenital melanocytic nevi.